41 – 50 of 144
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Challenges to informed consent in first-in-human trials involving novel treatments: A case study of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Pericytes in Neurodegeneration
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Device-Aided Treatment Strategies in Advanced Parkinson's Disease
(
- Contribution to journal › Article
- 2016
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
-
Mark
Health and social service access among family caregivers of people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
-
Mark
The restorative effect of PDGF-BB in Parkinson disease therapy
2016) FENS Forum 2016(
- Contribution to conference › Abstract
-
Mark
Life satisfaction in Parkinson's disease - associated factors
2016) The 20th International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article